This product is currently out of stock and unavailable.

SKU: N/A Category:


Vinpocetine Vials

CAS Number 42971-09-5
Molar Mass 350.5 g/mol
Chemical Formula C22H26N2O2
IUPAC Name ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo[,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate


Vinpocetine Peptide is a research product designed for scientific investigation and experimentation. This peptide, derived from the alkaloid vincamine found in the Vinca minor plant, has garnered attention for its potential cognitive and neuroprotective properties. It is crucial to emphasize that Vinpocetine Peptide is not intended for human consumption but is intended for research purposes only.

Key Characteristics

Vinpocetine Peptide is characterized by its ability to cross the blood-brain barrier, a crucial feature for substances intended to affect neurological processes. This characteristic opens avenues for exploring its impact on cognitive functions and neuroprotection.

Research Applications

Researchers utilize Vinpocetine Peptide to explore its potential applications in neuroscience and cognitive studies. The peptide’s interaction with cerebral blood flow and neuroprotective effects makes it a subject of interest in various research endeavors.

Research Benefits:

Vinpocetine and Memory Loss

Research studies have suggested that Vinpocetine Peptide may have cognitive-enhancing properties, particularly in addressing memory-related issues. Studies such as those conducted by Subhan et al. (2002) highlight the potential of Vinpocetine in improving memory functions.

Vinpocetine and Stroke

The neuroprotective effects of Vinpocetine Peptide have been explored in the context of stroke. Studies like the one by Feigin et al. (2001) indicate its potential to mitigate the impact of cerebral ischemia, presenting avenues for further investigation into stroke-related applications.

Vinpocetine and Alzheimer’s Disease

Research has also delved into the potential benefits of Vinpocetine Peptide in addressing neurodegenerative conditions such as Alzheimer’s disease. Studies, including those by Hindmarch et al. (1991), suggest that Vinpocetine may exhibit neuroprotective effects that could be relevant to Alzheimer’s research.


In summary, Vinpocetine Peptide, as a research product, holds promise in various neuroscience applications. Its potential cognitive benefits and neuroprotective effects make it a subject of interest for researchers exploring memory enhancement, stroke recovery, and neurodegenerative diseases.


  1. Subhan, Z., & Hindmarch, I. (1985). Psychopharmacological effects of vinpocetine in normal healthy volunteers. European Journal of Clinical Pharmacology, 28(Suppl), 567–571. [Read More].
  2. Feigin, V. L., et al. (2001). Vinpocetine treatment in acute ischaemic stroke: a pilot single-blind randomized clinical trial. European Journal of Neurology, 8(1), 81–85. [Read More].
  3. Hindmarch, I., et al. (1991). The effects of vinpocetine on cognitive performance in normal healthy volunteers. Psychopharmacology, 105(1), 6–9.[Read More].


There are no reviews yet.

Earn 10 points by reviewing this product.
Be the first to review “Vinpocetine”

Your email address will not be published. Required fields are marked *